Bluejay Diagnostics, Inc. Amortization of Debt Discount (Premium)
Bluejay Diagnostics, Inc. (BJDX) reported Amortization of Debt Discount (Premium) of $145.84 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2023-03-20
- Bluejay Diagnostics, Inc. amortization of debt discount (premium) for the quarter ending 2021-12-31 was -$122.94K.
- Bluejay Diagnostics, Inc. amortization of debt discount (premium) for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Bluejay Diagnostics, Inc. amortization of debt discount (premium) for the quarter ending 2020-12-31 was -$69.18K.
- Bluejay Diagnostics, Inc. amortization of debt discount (premium) for the quarter ending 2020-09-30 was $29.17K.
- Bluejay Diagnostics, Inc. amortization of debt discount (premium) for fiscal 2022 was $145.84K, a 536.87% increase from fiscal 2021.
- Bluejay Diagnostics, Inc. amortization of debt discount (premium) for fiscal 2021 was $22.90K, a 25.00% increase from fiscal 2020.
- Bluejay Diagnostics, Inc. amortization of debt discount (premium) for fiscal 2020 was $18.32K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2022-12-31 | $145.84K 10-K · filed 2023-03-20 | |||
| 2021-12-31 | -$122.94K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | -$122.94K derived: sum of 2 quarters · filed 2023-03-20 | $22.90K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-12-16 | $145.84K 10-Q · filed 2021-12-16 | ||
| 2020-12-31 | -$69.18K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$40.02K derived: sum of 2 quarters · filed 2022-03-10 | $18.32K 10-K · filed 2022-03-10 | |
| 2020-09-30 | $29.17K 10-Q · filed 2021-12-16 | $87.50K 10-Q · filed 2021-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |